deoxyglucose has been researched along with African Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, J; Gu, L; Ma, Z; Xie, L; Zhang, Y; Zhu, Y; Zuo, C | 1 |
| Cundliffe, B; Morser, J | 1 |
2 other study(ies) available for deoxyglucose and African Lymphoma
| Article | Year |
|---|---|
Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt Lymphoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Burkitt Lymphoma; Cell Cycle; Cell Line, Tumor; Deoxyglucose; Dexamethasone; Drug Resistance, Neoplasm; Drug Synergism; Glucocorticoids; Glycolysis; Humans; Mice; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Xenograft Model Antitumor Assays | 2015 |
The effect of inhibitors of glycosylation on interferon production in human lymphoblastoid cells.
Topics: Burkitt Lymphoma; Cell Line; Deoxy Sugars; Deoxyglucose; Glucosamine; Humans; Interferons; Lymphocytes; Neoplasm Proteins; RNA, Neoplasm | 1979 |